Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
Abd Hamid M., Wang R-Z., Yao X., Fan P., Li X., Chang X-M., Feng Y., Jones S., Maldonado-Perez D., Waugh C., Verrill C., Simmons A., Cerundolo V., McMichael A., Conlon C., Wang X., Peng Y., Dong T.